Skin Tolerance of Betamethasone Creams and Moisturiser Maintenance in Atopic Eczema

Phase 3, randomised trial of betamethasone valerate 0.1% cream and urea + glycerol cream in atopic dermatitis (AD) (4 arms), sponsored by ACO. Primary endpoints: Compatibility of the skin with the new formulation in comparison to the reference medication at 3 weeks and Effect of maintenance therapy with an emollient cream on the possible recurrence of atopic eczema up to 6 months. Started Jan 2004; status: completed.